Chris Oubridge 2026-11-05
Chris Oubridge investigated the structural basis of RNA splicing and RNA recognition by proteins. The original 1994 publisher record names him as first author of the U1A protein–RNA hairpin structure previously cited under C. Oubridge.[ref] His institutional obituary records 1966–2020 and describes his contributions to spliceosome structural studies.[ref]
The 1994 X-ray crystallography study resolved an RNA-binding domain with a 21-nucleotide RNA hairpin with a resolution of 1.92 angstroms. Its ten-nucleotide loop lies on the domain's beta sheet; contacts involving the loop sequence include hydrogen bonds. This provides a physical explanation of sequence recognition, rather than treating a matching letter sequence as sufficient without a compatible RNA structure.[ref]
For an original affinity example, suppose changing a loop raises a measured dissociation constant from to . At 298 kelvin, the corresponding change in standard binding Gibbs free energy is
where is the molar gas constant. These are stipulated values, not measurements from the 1994 paper. A structure can motivate which contacts to test, while an independent binding affinity measurement establishes the net energetic effect; counting visible contacts alone does not supply that effect.
Oubridge also shared first authorship of the 2009 U1 snRNP functional-core structure, connecting the study of an individual recognition domain with the arrangement of RNA and proteins in a larger assembly.[ref]
Figure 1.
Chris Oubridge in the laboratory, named photograph in the MRC Laboratory of Molecular Biology obituary
.
Martin Leverkus 2026-11-05
Martin Leverkus coauthored the 2016 crystal violet assay protocol with Maria Feoktistova and Peter Geserick. The paper's affiliations connect the collaboration with molecular dermatology at Mannheim and dermatology at Aachen.[ref] Its scientific value includes making an assay's biological interpretation explicit: less retained stain does not, by itself, identify a particular mechanism of cell death.
A useful distinction is between reduced cell proliferation and increased cell death. An original constant-rate model gives
where and are per-cell proliferation and death rates. Parameter pairs and give the same net growth rate. Starting from 10000 cells, both predict approximately 14918 after ten hours, although only the first model includes ongoing deaths.
A staining endpoint proportional to retained cell number would not distinguish those two histories. Time-resolved counting or a measurement specific to a death process supplies additional information. Moreover, altered attachment or staining can invalidate the assumed proportionality before that biological comparison even begins. This is why the protocol's requirement for additional characterization matters.[ref] The calculation is an original identifiability example, not a reconstruction of Leverkus's data.
Figure 1.
Martin Leverkus, portrait accompanying the Cell Death Discovery memorial
. External portrait from the memorial to Martin Leverkus.
Tim R. Mosmann 2026-11-05
Tim R. Mosmann is an immunology researcher whose work includes quantitative cellular assays and analysis of T cell responses. His Rochester laboratory identifies him by this name and directly lists the 1983 colorimetric-assay paper published as T. Mosmann. This provides an institutional link between the initial-only byline and the named researcher; the R. is retained without expansion.[ref]
In 1983, Tim R. Mosmann reported a tetrazolium salt-based colorimetric method for mammalian cell survival, cell proliferation and activation. The paper's abstract describes a multiwell scanning spectrophotometer readout and explicitly notes that signal depends on activation. The experimental contribution therefore includes both a convenient quantitative assay and a qualification on its biological interpretation.[ref]
An original measurement model illustrates that qualification. Suppose a background-corrected signal is , where is the number of contributing cells, their mean per-cell reducing activity under the assay conditions and an instrumental factor. Doubling at unchanged doubles the signal, but doubling at unchanged does too. The single scalar signal does not identify both quantities.
For stipulated initial and , the products for later populations and are both 200. A larger readout alone cannot distinguish proliferation from increased activity per cell. Conversely, halving cell number while doubling mean activity can leave the total unchanged. These are model examples, not data from the 1983 paper.
Controls with known cell numbers, appropriate blanks and independent biological observations help establish which interpretation applies. The general lesson is to connect cell viability and cell proliferation claims to a validated response model, rather than assigning every absorbance change to one mechanism.
The laboratory also describes computational analysis of high-dimensional flow cytometry measurements of T cells.[ref] That scientific setting likewise requires distinguishing a measured signal pattern from the underlying populations it is intended to represent.
Figure 1.
Tim R. Mosmann, portrait explicitly named on the Rochester Mosmann laboratory members page
.